Gold - Dinner Sponsor
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. As an independent company, we plan in generations and focus on long-term success. Our goal is to improve the health and quality of life of patients and our focus is on diseases for which no satisfactory treatment option exists.
As a research-driven company, we actively collaborate with the oncology community to deliver scientific breakthroughs to transform the lives of patients. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer.